Consolidated Statements of Changes in Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands		Common Stock	Retained earnings	Treasury stock	Accumulated other comprehensive (loss) income	Total
Balance, beginning of period at Dec. 31, 2023		$ 100,426	$ 191,108	$ (27,367)	$ (2,737)	$ 261,430
Balance, beginning of period (in shares) at Dec. 31, 2023		10,063
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)			9,586			9,586
Other comprehensive income, net of tax					(115)	(115)
Dividends on common stock		$ 53	(1,314)			(1,261)
Dividends on common stock (in shares)		2
Share-based compensation	[1]	$ 1,197				1,197
Share-based compensation (in shares)	[1]	129
Treasury stock purchased, at cost				(4,076)		(4,076)
Treasury stock purchased, at cost (in shares)		(150)
Balance, end of period at Mar. 31, 2024		$ 101,676	199,380	(31,443)	(2,852)	266,761
Balance, end of period (in shares) at Mar. 31, 2024		10,044
Balance, beginning of period at Dec. 31, 2024		$ 103,936	227,331	(33,577)	(2,107)	$ 295,583
Balance, beginning of period (in shares) at Dec. 31, 2024		10,026				10,026
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)			11,598			$ 11,598
Other comprehensive income, net of tax					275	275
Dividends on common stock		$ 56	(1,411)			(1,355)
Dividends on common stock (in shares)		1
Share-based compensation	[1]	$ 41				41
Share-based compensation (in shares)	[1]	49
Balance, end of period at Mar. 31, 2025		$ 104,033	$ 237,518	$ (33,577)	$ (1,832)	$ 306,142
Balance, end of period (in shares) at Mar. 31, 2025		10,076				10,076

[1] Includes the issuance of common stock under employee benefit plans, which includes nonqualified stock options and restricted stock expense related entries, employee option exercises and the tax benefit of options exercised.